• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assay Kits
      • Transcreener® ADP² Kinase Assay Kits
        • Transcreener® ADP2 Assay Kit – FP Readout
        • Transcreener® ADP2 Assay Kit – FI Readout
        • Transcreener® ADP2 Assay Kit – TR-FRET Readout
      • Transcreener® ADO CD73 Assay Kit
      • Transcreener® ADPR Assay Kit
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay Kits
        • Transcreener® AMP2/GMP2 FP Assay
        • Transcreener® AMP2/GMP2 Assay Kit – TR-FRET Readout
      • Transcreener® cGAMP cGAS Assay Kits
        • Transcreener® cGAMP Assay Kit – FP Readout
        • Transcreener® cGAMP Assay Kit – TR-FRET Readout
      • Transcreener dAMP Exonuclease Assay Kit
      • Transcreener® EPIGEN SAH Methyltransferase Assay Kit
      • Transcreener® GDP GTPase Assay Kits
        • Transcreener® GDP Assay Kit – FP Readout
        • Transcreener® GDP Assay Kit – FI Readout
        • Transcreener® GDP Assay Kit – TR-FRET Readout
      • Transcreener® UDP² Glycosyltransferase Assay Kits
        • Transcreener® UDP2 Assay Kit – FP Readout
        • Transcreener® UDP2 Assay Kit – FI Readout
        • Transcreener® UDP2 Assay Kit – TR-FRET Readout
      • Transcreener® 2-5A OAS Assay Kit
    • AptaFluor® HTS Assay Kits
      • AptaFluor® SAH Methyltransferase Assay Kit
    • Enzyme Assay Systems
      • CD38 Assay System
      • PARG Assay System
      • TREX1 Assay System
      • WRN Helicase Assay System
    • Recombinant Enzymes
      • Human CD38 Enzyme
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
      • Human PARG Enzyme
      • Human TREX1 Enzyme
      • Human WRN Helicase Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • GTPase Profiling Services
    • ATPase Profiling Services
  • Assays by Target
    • Kinase Assays
      • ADK Assays – Application
      • AMPK Assays – Application
      • IKK-beta Assays – Application
      • IRAK4 Assays – Application
      • JAK1 Assays – Application
      • JAK3 Assays – Application
      • MAPK8 Assays – Application
      • PKR Assays – Application
      • RIPK1 Assays – Application
      • RIPK2 Assays – Application
      • TBK1 Assays – Application
    • GTPase Assays
      • GAP Assays – Application
      • GEF Assays – Application
      • KRAS Assays – Application
      • HRAS Assays – Application
      • NRAS Assays – Application
      • RRAS Assays – Application
      • Rac1 Assays – Application
      • RhoA Assays – Application
      • RhoC Assays – Application
      • Cdc42 Assays – Application
      • Ran Assays – Application
    • Methyltransferase Assays
      • EZH2 Assays – Application
      • G9a Assays – Application
      • METTL3/METTL14 Assays – Application
      • SET7/9 Assays – Application
      • SET8 Assays – Application
      • PRMT1 Assays – Application
      • PRMT3 Assays – Application
      • PRMT4 Assays – Application
      • PRMT5 Assays – Application
    • STING Pathway Assays
      • cGAS Assay Kits
      • ENPP1 Assays – Application
      • TREX1 Assay System
      • IKK-beta Assays – Application
      • TBK1 Assays – Application
    • Nucleotidase Assays
      • CD38 Assay System
      • CD39 Assays – Application
      • CD73 Activity Assay Kits
      • PARG Assay System
    • Helicase / ATPase Assays
      • DDX3 Assays – Application
      • NSP13 Assays – Application
      • p97 Assays – Application
      • Ketohexokinase Assays – Application
      • WRN Helicase Assay System
    • Glycosyltransferase Assays
      • Toxin B Assays – Application
      • GALNT2 Assays – Application
      • GALNT3 Assays – Application
      • BGalT1 Assays – Application
    • Phosphodiesterase Assays
      • PDE3 Assays – Application
      • PDE4 Assays – Application
      • PDE5 Assays – Application
      • PDE7 Assays – Application
    • Ligase and Synthetase Assays
      • SUMO E1 Assays – Application
      • Acetyl CoA Synthetase Assays – Application
    • Exonuclease Assays
      • TREX1 Assay System
      • WRN Exonuclease Assays – Application
    • OAS Assays
      • OAS1 Assay Kits
    • Other Enzyme Assays
      • NUDT5 Assays – Application
  • Resources
    • Technical Manuals
    • Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
      • DNA Damage Response and Innate Immunity
    • Technical Support
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

NSP16 Shows Promise for Anti-Viral Therapeutics

by Bellbrook Labs / Tuesday, 20 September 2022 / Published in Emerging Targets, HTS Assays, Innate Immunity
NSP16 Target for COVID-19 Therapeutics

SARS-CoV-2 virus (Covid-19) possesses one of the largest genomes of any RNA virus. While it naturally encodes structural proteins among its 29 genes, it also produces non-structural proteins that are necessary to perpetuate infection. Non-structural protein 16 (NSP16) is one such protein.1

NSP16 Camouflages Viral mRNA

NSP16 is an m7GpppA-specific, S-adenosyl-L-methionine-dependent 2’-O-methyltransferase (2’-O-MTase) that “caps” virally transcribed mRNA to protect it from host innate immune defenses. This capping involves the transfer of a methyl group from NSP16’s S-adenosyl-L-methionine (SAM) cofactor to the 2’ hydroxyl ribose sugar at the 5’ end of the viral mRNA. This type 1 cap consists of a N-methylated guanosine triphosphate and C-2’-O-methyl-ribosyladenine and is fabricated in the cytoplasm. In human cells, this cap is installed in the nucleus by host proteins, such as CMTr1. For both host and pathogen, this cap serves to mark their mRNA as non-threatening, add stability, and increase translation efficiency. NSP16 induced mRNA capping effectively camouflages viral mRNA from host innate immune surveillance mechanisms, such as IFIT and RIG-I. As a result, the type 1 interferon defense remains effectively disengaged.2

However, unlike all other known 2’-O-MTases, NSP16 absolutely requires the assistance of another protein, SARS-CoV-2’s NSP10, to bind SAM or viral mRNA. In detail, NSP10 activates NSP16 by stabilizing its SAM and RNA binding pockets, permitting a stable catalytic complex to form. While it may initially seem like a good idea to interfere with SAM binding to impede the capping process, SAM is required by several host enzymes.3

Cryptic Pockets as Hopeful Ways to Inhibit NSP16 Activity

Recent work has focused upon what are known as “cryptic pockets” that occur as part of regular protein conformational shifts. These conformational shift sites, if stabilized or “jammed open” may offer new ways to inhibit enzymatic activity. NSP16 has just such a pocket in the form of the space between its Beta 3 and Beta 4 sheets. When Beta 4 moves away from Beta 3, it not only closes the SAM binding site, but also disrupts the NSP10 binding region. Any inhibitor that could occupy and stabilize this conformation, should effectively inactivate NSP16. To date, this pocket has been found to be highly conserved in the MERS and SARS virus families, but not at all among host 2’-O-MTases. This is a very promising avenue for future therapeutic endeavors.4

BellBrook’s own AptaFluor SAH Methyltransferase Assay may prove indispensable in finding selective inhibitors that act on select cryptic pockets. Essentially, when SAM is used in methylation by methyltransferases, S-adenosylhomocysteine (SAH) is produced as a by-product. This assay utilizes an aptamer to selectively bind to any generated SAH. Time-resolved fluorescence resonance energy transfer detection further enhances the exquisite sensitivity of this proprietary assay, detecting SAH at concentrations as low as 0.6 nM.

Check Out The Aptafluor SAH Assay

References

1. Chang, L-J and Chen, T-H. (2021) NSP16 2′-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies. Viruses, 13(4):538. Review. https://doi.org/10.3390/v13040538

2. Krafcikova, P. et al. (2020) Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nature Communications, 11:3717. https://doi.org/10.1038/s41467-020-17495-9

3. Sk, M.F. et al. (2020) Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM. Frontiers in Molecular Biosciences, 7:590165. https://doi.org/10.3389/fmolb.2020.590165

4.  Vithani, N. et al. (2021) SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential. Biophysical Journal, 120(14), 2880-2889. https://doi.org/10.1016/j.bpj.2021.03.024

Tagged under: AptaFluor SAH Methyltransferase Assay, COVID-19, Innate Immunity, NSP16

What you can read next

Transcreener® Assays Help Feed Epigenetics Drug Pipeline Down Under
glycogen synthase diabetes
Using Glycogen Synthase Assays in the Quest for Type 2 Diabetes Therapies  
Greatwall: Cancer’s Great Defender?

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • RNA Methyltransferase METTL16 Performing Many Functions

    METTL16: An RNA Methyltransferase That Wears Many Hats

    Methyltransferase-like protein 16 (METTL16) is ...
  • Researchers Identify PDE5 Inhibitor Using Transcreener Assay

    Researchers Use Transcreener Assay to Identify New PDE5 Inhibitor

    Phosphodiesterase 5 (PDE5) is most familiar in ...
  • DDX6 regulates RNA transcription and translation

    DDX6 Regulates mRNA Transcription & Translation Pathways

    DDX6 (RCK/p54) was first isolated from the RC-K...
  • Scientist using Transcreener Assay to Study PIK3CA Mutation

    Transcreener ADP2 Assay Helps Uncover the Mechanics of Oncogenic PIK3CA Mutations

    The PIK3CA gene codes for the 110 kDa catalytic...
  • DDX5 Inhibitors Targeting Colon Cancer

    Targeting DDX5 Inhibitors to Battle Cancers & Viral Infections

    DDX5 (Dead-Box 5 or p68) is a member of a famil...

Archives

BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2023 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP